Overview
- 115 inspections across 106 sites are on record.
- 200 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2016-03-29.
At a glance
Inspections
115
Sites
106
Observations
200
Career since
Feb 2008
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| MSKCC RMIPC | 29 Mar 2016 | Human Drugs | View 483 → |
| Topix Pharmaceuticals Inc | 21 Jan 2016 | Human Drugs | On file |
| Advance Pharmaceutical, Inc. | 2 Dec 2015 | Human Drugs | View 483 → |
| Townley Inc | 4 Nov 2015 | Human Drugs | |
| Pfizer Inc. | 26 Aug 2015 | Human Drugs | View 483 → |
Sites inspected
MSKCC RMIPCNew York, United States1 insp.
Topix Pharmaceuticals IncAmityville, United States1 insp.
Advance Pharmaceutical, Inc.Holtsville, United States1 insp.
Townley IncNew York, United States1 insp.
Pfizer Inc.New York, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Parul M Patel6 shared
Burnell M Henry6 shared
Kenneth H Williams4 shared
Susanna E Ford4 shared
Rachael A Moliver3 shared
Jose O Hernandez3 shared
Michael E Maselli3 shared
Ralph H Vocque3 shared
Rochelle L Cross3 shared
Russell K Riley3 shared
Full investigator report
Get the verbatim findings behind Charisse K Green's 200 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site